肺移植围手术期体外膜肺氧合应用指南（2019版）

中华医学会器官移植学分会; 国家肺移植质量管理与控制中心

doi:10.3969/j.issn.1674-7445.2019.04.009

肺移植围手术期体外膜肺氧合应用指南（2019版）

doi: 10.3969/j.issn.1674-7445.2019.04.009

214023 无锡，南京医科大学附属无锡人民医院胸外科暨肺移植中心（陈静瑜、毛文君、杨柯佳、陈若）；中日友好医院（李敏、顾思超）；复旦大学附属中山医院（李欣）

基金项目:

江苏省科教强卫项目 JCRCB2016003

无锡市卫计委科研重大项目 Z201801

详细信息

通讯作者:
陈静瑜，男，1963年生，主任医师，研究方向为肺移植，Email：chenjy@wuxiph.com

中图分类号: R617, R563
计量
- 文章访问数: 710
- HTML全文浏览量: 371
- PDF下载量: 114
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-23
- 网络出版日期: 2021-01-19
- 刊出日期: 2019-07-15

Guideline on the application of extracorporeal membrane oxygenation during the perioperative period of lung transplantation(2019 edition)

摘要

摘要: 肺移植是治疗多种终末期肺疾病的唯一有效方法，体外膜肺氧合（ECMO）在肺移植围手术期起到重要的桥接和支持作用。本指南从肺移植术前ECMO的桥接治疗、术中的心肺支持及术后功能维持等方面，总结肺移植临床实践经验，以期为我国肺移植相关临床科室提供工作指引。

HTML全文

图 1 ECMO双极静脉插管示意图^[1]

Figure 1. Schematic diagram of ECMO bipolar venous intubation

下载: 全尺寸图片幻灯片

参考文献(32)

[1]	LOOR G, SIMPSON L, PARULEKAR A. Bridging to lung transplantation with extracorporeal circulatory support: when or when not?[J]. J Thorac Dis, 2017, 9(9):3352-3361. DOI: 10.21037/jtd.2017.08.117.
[2]	KEARNS SK, HERNANDEZ OO. "Awake" extracorporeal membrane oxygenation as a bridge to lung transplant[J]. AACN Adv Crit Care, 2016, 27(3):293-300. doi: 10.4037/aacnacc2016792
[3]	HAKIM AH, AHMAD U, MCCURRY KR, et al. Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation[J]. Ann Thorac Surg, 2018, 106(1):192-198. DOI: 10.1016/j.athoracsur.2018.02.036.
[4]	LEE SG, SON BS, KANG PJ, et al. The feasibility of extracorporeal membrane oxygenation support for inter-hospital transport and as a bridge to lung transplantation[J]. Ann Thorac Cardiovasc Surg, 2014, 20(1):26-31. doi: 10.5761/atcs.oa.12.00203
[5]	龙村.体外膜肺氧合循环支持专家共识[J].中国体外循环杂志, 2014, 12(2):65-67. DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01. LONG C. Expert consensus on extracorporeal membrane oxygenation circulation support[J]. Chin J Extra Circ, 2014, 12(2):65-67.DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01.
[6]	REEB J, OLLAND A, RENAUD S, et al. Vascular access for extracorporeal life support: tips and tricks[J]. J Thorac Dis, 2016, 8(Suppl 4):S353-S363. DOI: 10.21037/jtd.2016.04.42.
[7]	DOUFLÉ G, FERGUSON ND. Monitoring during extracorporeal membrane oxygenation[J]. Curr OpinCrit Care, 2016, 22(3):230-238. DOI: 10.1097/MCC.0000000000000309.
[8]	LUYT CE, BRÉCHOT N, DEMONDION P, et al. Brain injury during venovenous extracorporeal membrane oxygenation[J]. Intensive Care Med, 2016, 42(5):897-907. DOI: 10.1007/s00134-016-4318-3.
[9]	CHEN H, YU RG, YIN NN, et al. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review[J]. Crit Care, 2014, 18(6):675. DOI: 10.1186/s13054-014-0675-x.
[10]	GARCIA JP, KON ZN, EVANS C, et al. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls[J]. J Thorac Cardiovasc Surg, 2011, 142(4):755-761. DOI: 10.1016/j.jtcvs.2011.07.029.
[11]	IUS F, SOMMER W, TUDORACHE I, et al. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes[J]. Interact Cardiovasc Thorac Surg, 2015, 20(6):761-767. DOI: 10.1093/icvts/ivv035.
[12]	PARK BW, LEE SR, LEE MH, et al. Short stature is associated with the development of lower limb ischaemia during extracorporeal life support[J]. Perfusion, 2018, 33(5):383-389. DOI: 10.1177/0267659118755273.
[13]	MCRAE K, DE PERROT M. Principles and indications of extracorporeal life support in general thoracic surgery[J]. J Thorac Dis, 2018, 10(Suppl 8):S931-S946. DOI: 10.21037/jtd.2018.03.116.
[14]	PORTEOUS MK, LEE JC. Primary graft dysfunction after lung transplantation[J]. Clin Chest Med, 2017, 38(4):641-654. DOI: 10.1016/j.ccm.2017.07.005.
[15]	MULVIHILL MS, YEROKUN BA, DAVIS RP, et al. Extracorporeal membrane oxygenation following lung transplantation: indications and survival[J]. J Heart Lung Transplant, 2017: S1053-2498(17)31880-6. DOI: 10.1016/j.healun.2017.06.014.
[16]	SHARGALL Y, GUENTHER G, AHYA VN, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅵ: treatment[J]. J Heart Lung Transplant, 2005, 24(10):1489-1500. doi: 10.1016/j.healun.2005.03.011
[17]	BRODIE D, BACCHETTA M. Extracorporeal membrane oxygenation for ARDS in adults[J]. N Engl J Med, 2011, 365(20):1905-1914. DOI: 10.1056/NEJMct1103720.
[18]	GULACK BC, HIRJI SA, HARTWIG MG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation[J]. J Thorac Dis, 2014, 6(8):1070-1079. DOI: 10.3978/j.issn.2072-1439.2014.06.04.
[19]	CASTLEBERRY AW, HARTWIG MG, WHITSON BA. Extracorporeal membrane oxygenation post lung transplantation[J]. Curr Opin Organ Transplant, 2013, 18(5):524-530. DOI: 10.1097/MOT.0b013e328365197e.
[20]	ABRAMS D, BRODIE D, ARCASOY SM. Extracorporeal life support in lung transplantation[J]. Clin Chest Med, 2017, 38(4):655-666. DOI: 10.1016/j.ccm.2017.07.006.
[21]	MULLA H, LAWSON G, VON ANREP C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation[J]. Perfusion, 2000, 15(1):21-26. doi: 10.1177/026765910001500104
[22]	AHSMAN MJ, HANEKAMP M, WILDSCHUT ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates[J]. Clin Pharmacokinet, 2010, 49(6):407-419. DOI: 10.2165/11319970-000000000-00000.
[23]	WAGNER D, PASKO D, PHILLIPS K, et al. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation[J]. Perfusion, 2013, 28(1):40-46. DOI: 10.1177/0267659112456894.
[24]	SHEKAR K, ROBERTS JA, MULLANY DV, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure[J]. Anaesth Intensive Care, 2012, 40(4):648-655. doi: 10.1177/0310057X1204000411
[25]	HA MA, SIEG AC. Evaluation of altered drug pharmacokinetics in critically Ill adults receiving extracorporeal membrane oxygenation[J]. Pharmacotherapy, 2017, 37(2):221-235. DOI: 10.1002/phar.1882.
[26]	ABRAMS D, JAVIDFAR J, FARRAND E, et al. Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study[J]. Crit Care, 2014, 18(1):R38. DOI: 10.1186/cc13746.
[27]	KO Y, CHO YH, PARK YH, et al. Feasibility and safety of early physical therapy and active mobilization for patients on extracorporeal membrane oxygenation[J]. ASAIO J, 2015, 61(5):564-568. DOI: 10.1097/MAT.0000000000000239.
[28]	LINKINS LA, DANS AL, MOORES LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl):e495S-e530S. DOI: 10.1378/chest.11-2303.
[29]	MARASCO SF, LUKAS G, MCDONALD M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients[J]. Heart Lung Circ, 2008, 17 (Suppl 4):S41-S47. DOI: 10.1016/j.hlc.2008.08.009.
[30]	AISSAOUI N, EL-BANAYOSY A, COMBES A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation[J]. Intensive Care Med, 2015, 41(5):902-905. DOI: 10.1007/s00134-015-3663-y.
[31]	AISSAOUI N, LUYT CE, LEPRINCE P, et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock[J]. Intensive Care Med, 2011, 37(11):1738-1745. DOI: 10.1007/s00134-011-2358-2.
[32]	MENAKER J, TABATABAI A, RECTOR R, et al. Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation[J]. ASAIO J, 2017, 63(5):588-591. DOI: 10.1097/MAT.0000000000000539.